Abstract| Volume 39, ISSUE 9, SUPPLEMENT , e33, September 2014

Treatment of Recurrent Dupuytren Contractures in Joints Previously Effectively Treated With Collagenase Clostridium Histolyticum: Final Results

Level 2 Evidence
      Recurrent Dupuytren’s contracture is common regardless of the initial intervention. Collagenase clostridium histolyticum (CCH) is approved for treatment of adult patients with Dupuytren’s contracture with a palpable cord. This study assessed safety and efficacy of CCH for the retreatment of recurrent contractures in joints that were previously effectively treated with CCH.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hand Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect